Ticker > Company >

Suraksha Diagnostic share price

Suraksha Diagnostic Ltd.

NSE: SURAKSHA BSE: 544293 SECTOR: Hospital & Healthcare Services  26.97 K   17   10

299.80
+1.70 (0.57%)
BSE: 29 Sep 04:01 PM

Price Summary

Today's High

₹ 312

Today's Low

₹ 297.55

52 Week High

₹ 449

52 Week Low

₹ 233.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1561.38 Cr.

Enterprise Value

1551.68 Cr.

No. of Shares

5.21 Cr.

P/E

44.66

P/B

6.97

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  43

CASH

15.53 Cr.

DEBT

5.83 Cr.

Promoter Holding

48.88 %

EPS (TTM)

₹  6.71

Sales Growth

13.99%

ROE

17 %

ROCE

25.83%

Profit Growth

37.14 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.99%
3 Year3.73%
5 Year9.6%

Profit Growth

1 Year37.14%
3 Year12.08%
5 Year17.06%

ROE%

1 Year17%
3 Year12.11%
5 Year11.81%

ROCE %

1 Year25.83%
3 Year19.86%
5 Year17.66%

Debt/Equity

0.0272

Price to Cash Flow

24.86

Interest Cover Ratio

5.8459

CFO/PAT (5 Yr. Avg.)

2.46566034883025

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 48.88 0.00
Mar 2025 48.78 0.00
Dec 2024 48.78 0.00
Mar 2023 62.96 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 2.8114 Cr.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 25.60458% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -149.8447 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.46566034883025.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.89662255833797.

 Limitations

  • The company has shown a poor revenue growth of 3.72781060941803% for the Past 3 years.
  • The company is trading at a high PE of 44.66.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 65.95 58.57 64.15 70.28
Total Expenditure 42.37 40.48 44.32 46.44
Operating Profit 23.57 18.09 19.82 23.84
Other Income 1.26 0.98 0.94 1.1
Interest 2.07 2.03 2.06 2.66
Depreciation 8.58 8.62 8.66 9.15
Exceptional Items 0 0 0 0
Profit Before Tax 14.18 8.42 10.04 13.12
Tax 3.43 2.06 2.03 3.27
Profit After Tax 10.75 6.36 8.01 9.85
Adjusted EPS (Rs) 2.49 1.22 1.54 1.89

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 140.01 223.19 189.99 218.52 249.1
Total Expenditure 117.35 175.11 144.5 146.55 165.84
Operating Profit 22.65 48.09 45.49 71.97 83.26
Other Income 1.38 2.3 3.58 3.65 4.38
Interest 1.9 2.1 9.56 9.57 9.05
Depreciation 15.71 15.09 31.63 32.57 34.73
Exceptional Items 0 0 0 -0.78 0
Profit Before Tax 6.41 33.19 7.87 32.71 43.86
Tax -0.06 9.44 0.68 8.32 10.42
Net Profit 6.47 23.75 7.19 24.38 33.44
Adjusted EPS (Rs.) 93.83 344.22 104.19 353.39 6.42

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 8.53 8.53 8.53 8.53 10.42
Total Reserves 117.73 141.49 148.1 172.34 203.9
Borrowings 9.93 12.28 8.43 5.18 2.88
Other N/C liabilities 9.94 10.36 78.96 76.46 77.7
Current liabilities 24.95 28.08 38.04 39.23 38.21
Total Liabilities 171.08 200.74 282.06 301.75 333.1
Assets
Net Block 118.99 119.31 195.05 211.41 215.15
Capital WIP 0.01 1.09 2.39 1.02 5.32
Intangible WIP 0.15 0 0 0 0.49
Investments 0.11 0.16 0.5 1.16 2.71
Loans & Advances 0 9.3 11.42 16.73 29.57
Other N/C Assets 24.51 49.01 5.04 0.68 35.58
Current Assets 27.32 21.86 67.65 70.76 44.27
Total Assets 171.08 200.74 282.06 301.75 333.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 6.41 33.19 7.87 32.71 43.86
Adjustment 21.32 15.84 39.65 41.2 41.73
Changes in Assets & Liabilities -2.69 -2.27 4.6 -4.08 -12.21
Tax Paid -1.5 -4.44 -7.19 -8.6 -10.58
Operating Cash Flow 23.54 42.33 44.93 61.23 62.8
Investing Cash Flow -27.71 -43.69 -22.04 -35.04 -39.28
Financing Cash Flow 3.21 1.09 -24.32 -25.83 -24.15
Net Cash Flow -0.96 -0.28 -1.44 0.36 -0.63

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Dec 2024% Mar 2025% Jun 2025%
promoters 62.96 48.78 48.78 48.88
bipul mittal - - - 0.03
dneema overseas private l... - 3.21 3.21 3.21
gopal krishna mittal huf - - - 0.03
late kishan kumar kejriwa... - - - 9.23
ritu mittal - - 15.89 15.89
satish kumar verma - 10.84 10.84 10.84
somnath chatterjee - - 4.99 5.04
tinni investments limited... - 4.62 4.62 4.62
kishan kumar kejriwal 11.15 9.23 9.23 -
ritu mittal 22.87 15.89 - -
somnath chatterjee 9.56 4.99 - -
satish verma 19.38 - - -
total 62.96 - - -
PARTICULARS Mar 2023% Dec 2024% Mar 2025% Jun 2025%
investors 37.04 51.22 51.22 51.12
aditya birla sun life tru... - 3.58 3.58 3.79
bandhan balanced advantag... - 1.13 - 1.33
carnelian bharat amritkaa... - - - 2.41
jm financial mutual fund ... - - - 1.12
kotak small cap fund - 5.00 5.84 5.84
nippon life india trustee... - 5.48 6.09 6.28
orbimed asia ii mauritius... - 12.88 12.88 12.88
quant mutual fund - quant... - 1.52 1.48 1.22
bandhan innovation fund - - 1.34 -
carnelian bharat amritkaa... - 2.10 2.41 -
dneema overseas pvt ltd. 3.87 - - -
munna lal kejriwal 2.56 - - -
orbimed asia ii mauritius... 19.51 - - -
sandip kejriwal 1.06 - - -
santosh kumar kejriwal 4.46 - - -
tinni investment ltd. 5.58 - - -
total 37.04 - - -

Annual Reports

Title Link
Title Link
Annual Report 2025

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research Ventura

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY25
Concall Q2FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY25

Company News

Suraksha Diagnostic informs about disclosures 18 Aug, 3:03 PM Suraksha Diagnostic submits press release 9 Aug, 4:00 PM Suraksha Diagnostic - Quaterly Results 8 Aug, 7:45 PM Suraksha Diagnostic - Quaterly Results 8 Aug, 7:45 PM Suraksha Diagnostic launches Genomics Lab in Eastern India 5 Jul, 4:00 PM Suraksha Diagnostic informs about disclosure 25 Jun, 5:34 PM Suraksha Diagnostic to invest Rs 200 crore to set up over 20 centres across eastern India 19 Jun, 11:49 AM Suraksha Diagnostic informs about disclosure 19 Jun, 9:39 AM Suraksha Diagnostic - Quaterly Results 28 May, 7:31 PM Suraksha Diagnostic - Quaterly Results 28 May, 7:31 PM Suraksha Diagnostic acquires 63% equity shares in Fetomat Wellness 10 Apr, 2:10 PM Suraksha Diagnostic informs about press release 7 Mar, 5:33 PM Suraksha Diagnostic informs about resignation of CFO and KMP 17 Feb, 5:29 PM Suraksha Diagnostic - Quaterly Results 8 Feb, 6:20 PM Suraksha Diagnostic - Quaterly Results 8 Feb, 6:20 PM Suraksha Diagnostic - Quaterly Results 8 Feb, 6:20 PM Suraksha Diagnostic informs about board meeting 3 Feb, 2:29 PM Suraksha Diagnostic informs about closure of trading window 26 Dec, 12:33 PM Suraksha Diagnostic informs about newspaper publication 21 Dec, 3:48 PM Suraksha Diagnostic informs about investor presentation 21 Dec, 2:06 PM Suraksha Diagnostic informs about investors meet 21 Dec, 1:18 PM Suraksha Diagnostic - Quaterly Results 20 Dec, 7:05 PM Suraksha Diagnostic - Quaterly Results 20 Dec, 7:05 PM Suraksha Diagnostic informs about disclosure 9 Dec, 1:06 PM Suraksha Diagnostic coming with IPO to raise upto Rs 846 crore 28 Nov, 10:34 AM Suraksha Diagnostic gets Sebi's nod to float IPO 8 Oct, 12:24 PM

Suraksha Diagnostic Stock Price Analysis and Quick Research Report. Is Suraksha Diagnostic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Suraksha Diagnostic. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Suraksha Diagnostic has a PE ratio of 44.4631497400295 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Suraksha Diagnostic has ROA of 10.5348% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Suraksha Diagnostic has a Current ratio of 1.1586.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Suraksha Diagnostic has a ROE of 17.0032%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Suraksha Diagnostic has a Debt to Equity ratio of 0.0272 which means that the company has low proportion of debt in its capital.

  • Sales growth: Suraksha Diagnostic has reported revenue growth of 13.9896% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Suraksha Diagnostic for the current financial year is 33.4232587193501%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Suraksha Diagnostic is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Suraksha Diagnostic is Rs 6.7123. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Suraksha Diagnostic in Ticker for free. Also, one can get the intrinsic value of Suraksha Diagnostic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Suraksha Diagnostic FAQs

Q1. What is Suraksha Diagnostic share price today?
Ans: The current share price of Suraksha Diagnostic is Rs 298.45.

Q2. What is the market capitalisation of Suraksha Diagnostic?
Ans: Suraksha Diagnostic has a market capitalisation of Rs 1554.35022251 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Suraksha Diagnostic?
Ans: The PE ratio of Suraksha Diagnostic is 44.4631497400295 and the P/B ratio of Suraksha Diagnostic is 6.94064925128429, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Suraksha Diagnostic share?
Ans: The 52-week high share price of Suraksha Diagnostic is Rs 449, and the 52-week low share price of Suraksha Diagnostic is Rs 231.

Q5. Does Suraksha Diagnostic pay dividends?
Ans: Currently, Suraksha Diagnostic does not pay dividends. Dividend yield of Suraksha Diagnostic is around 0%.

Q6. What are the face value and book value of Suraksha Diagnostic shares?
Ans: The face value of Suraksha Diagnostic shares is Rs 2, while the book value per share of Suraksha Diagnostic is around Rs 43.0003. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Suraksha Diagnostic?
Ans: Suraksha Diagnostic has a total debt of Rs 5.8252 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Suraksha Diagnostic?
Ans: The ROE of Suraksha Diagnostic is 17.0032% and ROCE of Suraksha Diagnostic is 25.8328%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Suraksha Diagnostic a good buy for the long term?
Ans: The Suraksha Diagnostic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Suraksha Diagnostic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Suraksha Diagnostic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Suraksha Diagnostic’s financials?
Ans: You can review Suraksha Diagnostic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Suraksha Diagnostic
X